MaxCyte

MaxCyte Introduces Rapid, Automated, Scalable Flow Electroporation-based Technology for Vaccine Development

Data on the use of MaxCyte electroporation to transfect insect cells without baculovirus to be presented. March 20, 2014 MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, will present data in both a scientific talk and a poster during the World Vaccine Congress on March 24-26, 2014, that demonstrates the use of flow electroporation for the rapid and …

Top 3 presentations on influenza vaccine production and pandemic readiness

We cannot ever be sure another influenza pandemic won't hit Europe soon, so better to be prepared this time from having looked at the learnings from past years. Below I have gathered our top 3 presentations on the topic of influenza vaccine production and our pandemic readiness.  Comment below if you have any opinions on the subject. Helmut Walerius from …